[Effects of PGE1 (alprostadil alpha-cyclodestrin) in a case of probable paraneoplastic thrombocytopenic purpura].
The authors report the case of a severely vasculopathic patient with pulmonary mediastinal tumour who presented, probably on a paraneoplastic basis, the onset of severe thrombocytopenic purpura persisting for several months. The syndrome was not classifiable in any of the forms known to the authors and was completely resolved by treatment with PGE1 (alprostadil-alpha-cyclodextrine (Prostavasin, Schwarz Pharma).
Pettine
G
G
Regione Lombardia, Azienda Socio Sanitaria n. 9, Sondrio.
Fiumano
M
M
Muffatti
A
A
Avolio
A
A
Menozzi
G
G
Libera
E
E
Mollo
C M
CM
Ezechieli
S
S
D000368:Aged; D000527:Alprostadil / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010257:Paraneoplastic Syndromes / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*
D010975:Platelet Aggregation Inhibitors; D000527:Alprostadil
Effetti della PGE1 (alprostadil alpha-ciclodestrina) in un caso di porpora trombocitopenica verosimilmente paraneoplastica.